The role of economic evaluation in the pricing and reimbursement of medicines-Reference-Cited by-同舟云学术

The role of economic evaluation in the pricing and reimbursement of medicines

Published:1997-06 Issue:3 Volume:40 Page:199-215
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Drummond Michael,Jönsson Bengt,Rutten Frans

Publisher

Elsevier BV

Subject

Health Policy

Reference31 articles.

1. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including economic analysis;Commonwealth of Australia,1995

2. Ontario guidelines for economic analysis of pharmaceutical products;Ontario Ministry of Health,1994

3. Guidelines for economic evaluation of pharmaceuticals: Canada;Canadian Coordinating Office for Health Technology Assessment (CCOHTA),1994

4. Program established to evaluate cost-effectiveness of new prescription drugs;British Columbia Ministry of Health;News Release,1995

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling elements of value-based pricing from a pharmaceutical industry’s perspective: a scoping review;Frontiers in Pharmacology;2024-06-24

2. How Much Better is Faster? Value Adjustments for Health-Improvement Sequences;PharmacoEconomics;2023-05-03

3. Economic evaluation of genome-guided treatment in oncology;Economic Evaluation in Genomic and Precision Medicine;2023

4. Theoretical models for economic evaluation in genomic and personalized medicine;Economic Evaluation in Genomic and Precision Medicine;2023

5. Generating Appropriate and Reliable Evidence for Value Assessment of Medical Devices: An ISPOR Medical Devices and Diagnostics Special Interest Group Report;Journal of Medical Devices;2022-04-12